Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The median citation count of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The emerging value of 64Cu for molecular imaging and therapy12
Lung shunt and lung dose calculation methods for radioembolization treatment planning10
Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin10
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging10
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study10
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging9
An essential practice summary of the new EANM guidelines for parathyroid imaging9
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors9
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma9
Applicability of sentinel lymph node biopsy in papillary thyroid cancer9
Practice and prospects for PET/CT guided interventions9
Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer9
The role of PET imaging in inflammatory bowel diseases: state-of-the-art review8
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study8
Fully integrated [18F]FDG PET/MR in large vessel vasculitis8
IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications7
PET- and SPECT-based navigation strategies to advance procedural accuracy in interventional radiology and image-guided surgery7
Beta radioguided surgery: towards routine implementation?7
Functional and molecular thyroid imaging7
PSMA uptake on [68Ga]-PSMA-11-PET/CT positively correlates with prostate cancer aggressiveness7
Interventional nuclear medicine: a focus on radioguided intervention and surgery7
Radioiodine therapy of Graves' disease6
Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols6
Copper, PET/CT and prostate cancer: a systematic review of the literature6
Therapeutic applications of radioactive sources: from image-guided brachytherapy to radio-guided surgical resection5
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center5
Update on diagnosis and treatment of hyperthyroidism: ultrasonography and functional imaging5
Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions5
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?5
18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion?4
Radioiodine therapy of thyroid autonomy4
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?4
Integration of molecular imaging in the personalized approach of patients with adrenal masses4
Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature4
The role of laboratory medicine in the diagnosis of the hyperthyroidism4
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization4
Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism3
Contemporary update of SPECT tracers and novelties in radioguided surgery: a perspective based on urology3
Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer3
Prognostic value and optimal threshold of first thyroglobulin in low/intermediate risk DTC3
Current approach to surgical management of hyperthyroidism3
Role of 18F-NaF PET/CT in bone metastases3
Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer3
Medical treatment of thyrotoxicosis3
Predictive factors of preoperative sentinel lymph node detection in intermediate and high-risk endometrial cancer3
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response3
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer3
Graves' orbitopathy: a multidisciplinary approach3
Radiosynoviorthesis: almost seventy years of experience but still somewhat fameless3
Positron emission tomography-magnetic resonance imaging as a research tool in musculoskeletal conditions3
Theragnostic in neuroendocrine tumors3
The role of PET/CT in thyroid autoimmune diseases3
Changes over the years in radiopharmaceutical design2
Adding 64Cu radiopharmaceuticals to the toolkit of molecular imaging2
Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score2
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review2
Copper-64-immunoPET imaging: bench to bedside2
Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer2
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study2
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma2
Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers2
The sentinel node with technetium-99m for prostate cancer. A safe and mature new gold standard?2
Theragnostic radionuclides: a clinical perspective2
Theragnostics applications and challenges2
Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls2
Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism2
Extremity exposure of nuclear medicine workers: results from an EANM and EURADOS survey2
Theragnostics in primary and secondary liver tumors: the need for a personalized approach2
Improved automated synthesis of [18F]FINH-Me via direct radio-fluorination and quality control for Aβ-amyloid imaging1
Practical setting and potential applications of interventions guided by PET/MRI1
The role of fluorescent and hybrid tracers in radioguided surgery in urogenital malignancies1
Comparison of single photon emission computed tomography-computed tomography, computed tomography and magnetic resonance imaging of medication-related osteonecrosis of jaw by new calculated parameters1
Fever of unknown origin in pediatrics: role of nuclear medicine1
Uptake pattern of [68Ga]Ga-DOTA-NOC in tissues: implications for inflammatory diseases1
[18F]FDG PET/CT in rheumatoid arthritis1
Nuclear medicine and pediatric nephro-urology: a long-lasting successful partnership1
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients1
82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis1
Nuclear endocrinology in the era of precision medicine1
18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection1
Incidence of subclinical and overt hypothyroidism in children treated with [131I]mIBG: a systematic review and meta-analysis1
Contribution of positron emission tomography/magnetic resonance imaging in musculoskeletal malignancies1
Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma1
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases1
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis1
Current approach to pediatric differentiated thyroid cancer1
Role of intravoxel incoherent motion parameters in gastroesophageal cancer: relationship with 18F-FDG-positron emission tomography, computed tomography perfusion and magnetic resonance perfusion imagi1
Perceptual omission errors in positron emission tomography and computed tomography reporting1
Current update and future applications of bone metastasis imaging: what's next?1
Main challenges in radiation protection with emerging radionuclide therapies1
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans1
Long-term clinical results from 10 years follow-up after radiosynoviorthesis: a prospective observational study1
Application of a smart 18F-FDG-PET adaptive threshold segmentation algorithm for the biological target volume delineation in head and neck cancer1
Image-guided surgery: from classical techniques to novel aspects and approaches1
Correlation of 18F-FDG uptake and thyroid cancer stem cells1
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus1
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data1
Toxicity comparison of yttrium-90 resin and glass microspheres radioembolization1
Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma1
Peptide and pseudo-peptide1
Side effects of theragnostic agents currently employed in clinical practice1
Challenges in theragnostics1
Implementation of radioguided surgery in prostate cancer1
Radiation protection aspects for alpha therapies1
Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors1
0.032948970794678